Senator seeks information from FDA, 15 major retailers on products marketed to those suffering from Alzheimer’s, dementia, memory loss
WASHINGTON – U.S. Senator Claire McCaskill, the top-ranking Democrat on the Senate Special Committee on Aging, today began an examination of products, regulations, and retailers in the dietary supplement industry that specifically market to seniors using claims about improving memory and treating dementia and Alzheimer’s disease. One of the supplements, sold by retailer Amazon, was recently pulled from the online retailer’s website after McCaskill alerted the Food and Drug Administration to claims it made about ‘protecting against Alzheimer’s, Dementia, (and) Stroke…’. While that product is no longer sold on Amazon.com, similar products remain on Amazon’s website and the websites of several other national retailers. Click here to read more.